Clinical Trial Update: Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a nebivolol-valsartan combination for Stage 1 or Stage 2 hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BYSTOLIC (nebivolol hydrochloride)
• DIOVAN (valsartan)

Snippet

Sponsor: Forest Laboratories | Conditions: Stage 1 Hypertension, Stage 2 Hypertension | Phase 3 | Status: COMPLETED